NUTRITION 润色咨询

NUTRITION

出版年份:1987 年文章数:3656 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2024-06-17 ms9000000357155338 来自山东省

    需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2023-04-13 ms8000000584176615 来自浙江省

    submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2024-04-20 ms3000000138856379 来自浙江省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:医学;食品营养;meta
    经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2023-03-18 ms6000000049060211 来自山东省

    有点点慢哦,with editor已经一周了还没到下一步

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2023-02-14 ms9000001684545834 来自内蒙古

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:7月9日上传稿件
    7月14日Elsevier推荐了润色网站,没用
    10月23审稿意见返回
    11月4日返回审稿意见
    次年2月18日录用
    5月18日online
    审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-10-04 ms2000000734303055

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。
    总体是6月13日投,10月1号接收,不Open就不收费。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-06-28 zyl1997

    审稿速度:3.0
    经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-01-15 医路前行7575

    2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-05-31 ms8000000446291833

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:投过去润色结束后拒稿,离大谱

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2210297, encodeId=8ff9221029e31, content=需要所有作者确认才能到编辑手里吗?几天Submitted to Journal了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24f39045775, createdName=ms9000000357155338, createdTime=Mon Jun 17 12:30:21 CST 2024, time=2024-06-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2125687, encodeId=e612212568e44, content=submitted已经5天了,请问各位大佬是要所有作者confirm consent to be listed才能投出去嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e8396233, createdName=ms8000000584176615, createdTime=Thu Apr 13 14:55:26 CST 2023, time=2023-04-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2199490, encodeId=f28f21994908c, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:医学;食品营养;meta<br>经验分享:2月14日上传,4月3日给返修意见,4月16日上传修改稿,目前没有回信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83b89163764, createdName=ms3000000138856379, createdTime=Sat Apr 20 21:41:16 CST 2024, time=2024-04-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120269, encodeId=4b9221202693e, content=有点点慢哦,with editor已经一周了还没到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230318/6900c63e3c944c8b86ce17581c703c24/3b658afbddb647ca9ae157366084558c.jpeg, createdBy=2baf8436969, createdName=ms6000000049060211, createdTime=Sat Mar 18 11:15:51 CST 2023, time=2023-03-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114564, encodeId=df5421145640b, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:7月9日上传稿件<br>7月14日Elsevier推荐了润色网站,没用<br>10月23审稿意见返回<br>11月4日返回审稿意见<br>次年2月18日录用<br>5月18日online<br>审稿专家认真负责,投稿页面清晰明了,没得说,就是太太太慢了,后来又投了Elsevier旗下的期刊依旧很慢,大概六个月左右,虽然Elsevier的期刊口碑不错,但是时间成本太大了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e77a5516488, createdName=ms9000001684545834, createdTime=Tue Feb 14 12:13:47 CST 2023, time=2023-02-14, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2091790, encodeId=3b1e2091e9038, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:文章第一次投稿就选择这个期刊,投过去差不多两天就送审。两个月后返修,让一个月内返修好投过去。两个外审专家,提的意见很专业,发现了文章中很多的错误,耐心的解释后投回返修稿。返修稿投过去差不多15天后接收。<br>总体是6月13日投,10月1号接收,不Open就不收费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f496399340, createdName=ms2000000734303055, createdTime=Tue Oct 04 20:05:06 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229262, encodeId=79621229262fc, content=审稿速度:3.0<br>经验分享:一审3个月悲剧,只有一个审稿意见,只说了没有创新,没有其他意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=zyl1997, createdTime=Tue Jun 28 20:57:11 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184561, encodeId=99751184561a4, content=2021年9月投稿,1.6到现在decision in process。目前从投稿开始已经过去5个月了。等的好着急。有人一样吗?讨论讨论, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/a4f9d8c6800e44fa824f7e74efd2c24d/0eae19cbdd95437596b8f50851499247.jpg, createdBy=37145265487, createdName=医路前行7575, createdTime=Sat Jan 15 12:38:46 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223693, encodeId=8650122369315, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投过去润色结束后拒稿,离大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4da38187763, createdName=ms8000000446291833, createdTime=Tue May 31 20:03:33 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211576, encodeId=86be12115e649, content=珍爱生命,珍惜时间,远离nutrition, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8fbb5535407, createdName=Cc66889, createdTime=Fri Apr 15 23:43:09 CST 2022, time=2022-04-15, status=1, ipAttribution=)]
    2022-04-15 Cc66889

    珍爱生命,珍惜时间,远离nutrition

    2

    展开2条回复
共65条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分